Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magnet surgery aims to tame diabetes in tiny trial

NCT ID NCT07495787

First seen Mar 30, 2026 · Last updated Jun 23, 2026 · Updated 14 times

Summary

This study tests a new magnetic device that creates a connection between two parts of the small intestine, aiming to improve blood sugar control in type 2 diabetes. Only 5 adults with diabetes and a BMI between 25 and 50 will be enrolled. The main goal is to see if the device can be placed safely and pass through the body without problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AB Plus Speciality Hospital

    RECRUITING

    Ahmedabad, Gujarat, 380054, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Magnetic Compression Anastomosis device

What this could lead to

If it works, this could offer a new, less invasive surgical option to help control type 2 diabetes.

What could go wrong

This is a very early, tiny study with only 5 people. The device may not work as hoped, could cause complications like blockage or infection, and results may not apply to others.

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.